Centrum Zdrowia Metabolicznego Pawel Bogdanski
About Centrum Zdrowia Metabolicznego Pawel Bogdanski
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Centrum Zdrowia Metabolicznego Pawel Bogdanski
During the past decade, Centrum Zdrowia Metabolicznego Pawel Bogdanski conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
2009-04-01
2013-02-01
Completed
817
Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression
2010-11-01
2012-08-01
Completed
356
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
2013-12-01
2016-09-01
Completed
306
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
2016-11-07
2019-02-13
Completed
259
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Zdrowia Metabolicznego Pawel Bogdanski"
#1 collaborator was "Medpace, Inc." with 1 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Centrum Zdrowia Metabolicznego Pawel Bogdanski
According to Clinical.Site data, the most researched conditions in "Centrum Zdrowia Metabolicznego Pawel Bogdanski" are
"Cardiovascular Disease" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Chronic Kidney Disease (CKD)" (1 trials), "Diabetes" (1 trials) and "Dyslipidemias" (1 trials). Many other conditions were trialed in "Centrum Zdrowia Metabolicznego Pawel Bogdanski" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Zdrowia Metabolicznego Pawel Bogdanski
Most popular intervention types in "Centrum Zdrowia Metabolicznego Pawel Bogdanski" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Zdrowia Metabolicznego Pawel Bogdanski
The vast majority of trials in "Centrum Zdrowia Metabolicznego Pawel Bogdanski" are
7 trials for "All" genders.
Clinical Trials Status at Centrum Zdrowia Metabolicznego Pawel Bogdanski
Currently, there are NaN active trials in "Centrum Zdrowia Metabolicznego Pawel Bogdanski".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Centrum Zdrowia Metabolicznego Pawel Bogdanski,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Zdrowia Metabolicznego Pawel Bogdanski, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".